Steps towards simultaneously treating diabetes and fatty liver disease

Type 2 diabetes melilites (T2DM) is increasing in prevalence, currently affecting about 1 in 10 people. Normally, cells use sugar (glucose) for energy, and insulin enables the sugar to enter the cells.

Previous
Previous

Support, education, advocacy boost CGM use among youths with type 1 diabetes

Next
Next

Insulin resistance doubles risk of major depressive disorder, Stanford study finds